JUSTIN DAVID PUCKETT
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- KIRKSVILLE, MO
- NPI
- 1205044146
- Received
- $567,543 in 1,376 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 272 | $136,795 |
| 2024 | General payment | 172 | $70,261 |
| 2023 | General payment | 259 | $114,178 |
| 2022 | General payment | 216 | $90,714 |
| 2021 | General payment | 194 | $50,684 |
| 2020 | General payment | 104 | $28,042 |
| 2019 | General payment | 159 | $76,866 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 167 | $410,298 |
| Travel and Lodging | 277 | $67,119 |
| Consulting Fee | 18 | $55,699 |
| Food and Beverage | 906 | $23,385 |
| Honoraria | 3 | $7,538 |
| Compensation for serving as faculty or as a speaker for a medical education program | 1 | $3,400 |
| Education | 4 | $103 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-15 | Novo Nordisk Inc | $1 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-12-15 | Novo Nordisk Inc | $1 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-05 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-12-03 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-11-21 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-11-17 | Sumitomo Pharma America, Inc. | $14 | Food and Beverage | In-kind items and services | GEMTESA Drug, UROLOGY | 2025 | |
| 2025-11-11 | Aimmune Therapeutics, Inc. | $23 | Food and Beverage | In-kind items and services | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2025 | |
| 2025-11-10 | Amgen Inc. | $22 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-05 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-04 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-10-29 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-29 | Janssen Pharmaceuticals, Inc | $3 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-10-16 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2025 | |
| 2025-10-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-13 | KYOWA KIRIN, INC. | $19 | Food and Beverage | In-kind items and services | CRYSVITA Drug, FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | 2025 | |
| 2025-10-08 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-08 | Lundbeck LLC | $5 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-26 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-09-23 | Novo Nordisk Inc | $1,395 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-23 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-22 | Novo Nordisk Inc | $1,395 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-22 | Novo Nordisk Inc | $4 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-09-22 | Novo Nordisk Inc | $2 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-09-19 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-18 | GlaxoSmithKline, LLC. | $13 | Food and Beverage | In-kind items and services | AREXVY Biological, RESPIRATORY | 2025 | |
| 2025-09-17 | ABBVIE INC. | $108 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-16 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2025 | |
| 2025-09-05 | Novartis Pharmaceuticals Corporation | $26 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-09-04 | Lilly USA, LLC | $136 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-09-04 | Lilly USA, LLC | $40 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-09-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-21 | Lilly USA, LLC | $136 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-21 | Lilly USA, LLC | $53 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-21 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-20 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-08-15 | Ardelyx, Inc. | $19 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2025 | |
| 2025-08-13 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-08-13 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-12 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-12 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-12 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-11 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-11 | Lundbeck LLC | $12 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-08 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-04 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-04 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-04 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-31 | Lilly USA, LLC | $249 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-07-31 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-31 | Lilly USA, LLC | $9 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-28 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | PREVNAR 20 Biological, VACCINES | 2025 | |
| 2025-07-28 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-21 | Janssen Pharmaceuticals, Inc | $531 | Travel and Lodging | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-07-21 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-07-18 | Lilly USA, LLC | $139 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $287 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $280 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $47 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $41 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $24 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $18 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $17 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $8 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $8 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-09 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-09 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-07 | Novo Nordisk Inc | $12 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-05 | Janssen Pharmaceuticals, Inc | $4,145 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-07-03 | Lilly USA, LLC | $138 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-01 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-01 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-01 | Lundbeck LLC | $8 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-30 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-27 | Janssen Pharmaceuticals, Inc | $167 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-06-26 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-26 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-06-26 | Lilly USA, LLC | $9 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-06-25 | Lilly USA, LLC | $320 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-06-25 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-25 | Lilly USA, LLC | $4 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-20 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-20 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-20 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-19 | Exact Sciences Corporation | $14 | Food and Beverage | In-kind items and services | The Cologuard Plus Collection Kit Device, Oncology | 2025 | |
| 2025-06-17 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-17 | Lilly USA, LLC | $187 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-06-17 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-13 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-06-12 | Otsuka America Pharmaceutical, Inc. | $109 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-11 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-05 | Lilly USA, LLC | $9 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-04 | Lilly USA, LLC | $147 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-04 | Lilly USA, LLC | $147 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-04 | Lilly USA, LLC | $44 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-04 | Lilly USA, LLC | $23 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-04 | Lilly USA, LLC | $11 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-03 | Lilly USA, LLC | $147 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-03 | Lilly USA, LLC | $137 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-03 | Lilly USA, LLC | $25 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-03 | Lilly USA, LLC | $12 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-03 | Lilly USA, LLC | $4 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-30 | Janssen Pharmaceuticals, Inc | $1,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-30 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-30 | Janssen Pharmaceuticals, Inc | $256 | Travel and Lodging | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-30 | Janssen Pharmaceuticals, Inc | $161 | Travel and Lodging | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-30 | Janssen Pharmaceuticals, Inc | $7 | Food and Beverage | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-27 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-23 | Janssen Pharmaceuticals, Inc | $4,145 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-23 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-23 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-23 | Abbott Laboratories | $20 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-05-22 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-20 | Lilly USA, LLC | $139 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-05-20 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-20 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-19 | Lilly USA, LLC | $11 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-05-15 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-15 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-15 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-15 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-14 | Axsome Therapeutics, Inc. | $2,025 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-14 | Lilly USA, LLC | $124 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-14 | Axsome Therapeutics, Inc. | $112 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-14 | Axsome Therapeutics, Inc. | $51 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-14 | Lilly USA, LLC | $9 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-14 | Lundbeck LLC | $6 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-13 | Lilly USA, LLC | $140 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-05-13 | Lilly USA, LLC | $27 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-13 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-12 | Lilly USA, LLC | $70 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-12 | Lilly USA, LLC | $17 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-10 | Janssen Pharmaceuticals, Inc | $308 | Travel and Lodging | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-09 | Otsuka America Pharmaceutical, Inc. | $12 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-07 | Lilly USA, LLC | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-07 | Lilly USA, LLC | $120 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-07 | Lilly USA, LLC | $26 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-07 | Xeris Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | GVOKE HYPOPEN Drug, Diabetes | 2025 | |
| 2025-05-07 | Xeris Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | GVOKE HYPOPEN Drug, Diabetes | 2025 | |
| 2025-05-06 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-05 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-05 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-05 | Lilly USA, LLC | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-05 | Lilly USA, LLC | $155 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-05 | Lilly USA, LLC | $24 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-05 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-05-05 | Lilly USA, LLC | $6 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-02 | Janssen Pharmaceuticals, Inc | $853 | Travel and Lodging | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-01 | Novo Nordisk Inc | $12 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-30 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-29 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-29 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-29 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-28 | IDORSIA PHARMACEUTICALS US INC | $19 | Food and Beverage | In-kind items and services | Quviviq Drug, Insomnia | 2025 | |
| 2025-04-28 | Lundbeck LLC | $8 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-25 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-23 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-23 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-21 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-04-21 | Novo Nordisk Inc | $2 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-17 | Lilly USA, LLC | $140 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-17 | Lilly USA, LLC | $140 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-17 | Lilly USA, LLC | $113 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-17 | Lilly USA, LLC | $25 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-17 | Lilly USA, LLC | $13 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-17 | Lilly USA, LLC | $4 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-10 | Lilly USA, LLC | $110 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-10 | Lilly USA, LLC | $23 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-09 | AstraZeneca Pharmaceuticals LP | $108 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $4 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-08 | Axsome Therapeutics, Inc. | $3,600 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-04-08 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-08 | Lilly USA, LLC | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-07 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-07 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-07 | Lilly USA, LLC | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-07 | Lundbeck LLC | $9 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-04 | Lilly USA, LLC | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-03 | Lilly USA, LLC | $24 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-03 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-01 | Lilly USA, LLC | $83 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-01 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-26 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-03-24 | Lundbeck LLC | $8 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-03-22 | Janssen Pharmaceuticals, Inc | $5,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-03-20 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-19 | Janssen Pharmaceuticals, Inc | $12 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-03-19 | Lundbeck LLC | $5 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-03-18 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | M-M-R II Biological, VACCINE | 2025 | |
| 2025-03-03 | Lundbeck LLC | $8 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-24 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 |
The latest 200 records of 1,376.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Kirksville, MO, county Adair County, MO, state Missouri; placed by its city name.
| Measure | Place (city or town) Kirksville, MO | County Adair County, MO | State Missouri |
|---|---|---|---|
| Population B01003 | 17,563 | 25,301 | 6,191,814 |
| Population, 2020 census P1 | 17,530 | 25,314 | 6,154,913 |
| Median age B01002 | 24.8 | 30.2 | 39.0 |
| Under 18 B01001 | 18.5% | 18.7% | 22.3% |
| 65 and over B01001 | 12.9% | 15.4% | 17.9% |
| Households B11001 | 6,251 | 9,126 | 2,508,227 |
| Foreign born B05002 | 7.5% | 5.4% | 4.5% |
| Median household income B19013 | $50,071 | $61,536 | $70,702 |
| Median family income B19113 | $72,338 | $79,677 | $91,360 |
| Per capita income B19301 | $32,582 | $34,223 | $39,695 |
| Poverty rate B17001 | 28.2% | 22.0% | 12.6% |
| Unemployment rate B23025 | 4.0% | 4.1% | 4.0% |
| Civilian labor force B23025 | 7,448 | 11,421 | 3,120,639 |
| Mean commute (minutes) B08013 | 12.7 | 15.3 | 23.5 |
| Bachelor's degree or higher B15003 | 40.3% | 35.5% | 32.4% |
| Housing units B25001 | 7,609 | 11,389 | 2,825,287 |
| Owner-occupied B25003 | 48.3% | 61.0% | 68.1% |
| Renters B25003 | 51.7% | 39.0% | 31.9% |
| Median home value B25077 | $153,900 | $165,700 | $230,300 |
| Median gross rent B25064 | $775 | $772 | $1,033 |
| White, not Hispanic B03002 | 82.9% | 87.1% | 76.3% |
| Black B03002 | 6.4% | 4.4% | 10.9% |
| Hispanic or Latino B03002 | 3.7% | 3.0% | 5.2% |
| Asian B03002 | 2.9% | 2.1% | 2.1% |
| American Indian and Alaska Native B03002 | 0.4% | 0.3% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Kirksville, MO.
Comments